TOP2A was found be to overexpressed in HCC tissues [23], and TOP2A overexpression was correlated with early age onset of HCC, shorter HCC patients survival and chemoresistance [24], which is consistent with our findings that TOP2A predicted poor prognosis of HCC. Here, TOP2A is linked to hepatocellular carcinoma.